Overview

Vova Ida Therapeutics, Inc. (VIT) is a preclinical-stage biotech company developing therapeutics to prevent and/or treat age-related degenerative diseases including dementia and movement disorders. Leveraging its proprietary drug discovery platform, VIT developed several first-in-class neuroprotective small molecules restoring cellular bioenergetics. VIT’s preclinical and clinical development plan is designed to quickly show target engagement using disease-relevant biomarkers and clinical outcomes.